Europa Universalis 5 update 1.1 'Rossbach' is live, with an AI aggression overhaul, economic adjustments, more units, and army templates.

With several potential therapies, including Sepiapterin (PTC Therapeutics), NGGT002 (NGGT), JNT-517 (Jnana Therapeutics), Pegvaliase (BioMarin), and others under investigation, the phenylketonuria ...

The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such as Debio 4126 (Debiopharm International SA), ALXN2420 (AstraZeneca), MAR002 ...

Rügen and Usedom, long-cherished vacation spots for Europeans, are redefining what it means to be sustainable. Preservation ...

The AI-powered Epidemiology Database is a comprehensive repository covering 500+ disease indications with 10-year epidemiology forecasts across the seven ...

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

The total alopecia areata treatment market size is expected to grow positively by 2036 in the leading markets. The United States accounts for the largest market size of alopecia areata, in comparison ...

The chondrosarcoma market is anticipated to increase during the forecast period (2026-2036), owing to improved diagnosis, treatment advancements, increased awareness, the launch of emerging therapies ...

The atopic dermatitis market is expected to grow, driven by the extensive market penetration of approved therapies for moderate-to-severe atopic dermatitis and the entry of new therapies such as OX40 ...

The chondrosarcoma market is anticipated to increase during the forecast period (2026-2036), owing to improved diagnosis, treatment advancements, increased awareness, the launch of emerging therapies ...